Clinical Trial Update: Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating indigotindisulfonate sodium injection as an aid to determine ureteral patency in patients with ureteral injury; the trial is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureteral Injury

Drugs mentioned

• Indigotindisulfonate Sodium Injection, USP (indigotindisulfonate sodium)

Snippet

Sponsor: Prove pharm | Conditions: Ureter Injury | Phase 4 | Status: RECRUITING